
Martin Shkreli trial begins
34-year-old Shkreli, best known for hiking the price of a 70-year-old drug, Daraprim by 5000%, is headed to trial in a separate case for securities fraud.
34-year-old Shkreli, best known for hiking the price of a 70-year-old drug, Daraprim by 5000%, is headed to trial in a separate case for securities fraud.